Another study found advantageous vehicular effects on melanomas in mouse models [154]; MSC-exos containing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) were injected into the tumor, and demonstrated anti-tumor activity with a delayed appearance of tumor, though this did require multiple injections of the MSC-exos [154]. The gene discussed is TNFSF10; the disease is neoplasm.